文献速递肝病

NAFLD实践模式与治疗期望的国际调查——POP-NEXT项目

An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT project.
PubMed 文献 · Hepatology · 2022-04-26

在法国、德国、香港、意大利、罗马尼亚、西班牙、英国和美国对提供NAFLD专科诊疗的医生进行匿名调查,共664名医生完成。结果显示转诊路径存在重大缺陷和延迟、合并症筛查不完整、监测实践与现行指南不一致,且非药物干预可及性有限。

要点

  • 转诊前NAFLD很少被诊断且未做无创检测,转诊路径存在重大缺陷和延迟。
  • 专科医生对合并症筛查不完整且未计算心血管风险,监测实践与现行指南不一致。
  • 专科医生很少亲自实施饮食和生活方式干预,当地此类项目可及性高度异质。

核心结论

  • 该国际调查揭示了转诊路径的重大缺陷和延迟、合并症筛查或生活方式管理不理想,以及非药物干预当地可及性有限,监测实践与现行指南不一致。

研究设计与样本

  • 在法国、德国、香港、意大利、罗马尼亚、西班牙、英国和美国对提供NAFLD专科诊疗的医生进行匿名调查,共664名医生完成。

主要发现

  • 转诊至受访专科医生主要来自初级保健,转诊前NAFLD很少被诊断且未进行无创检测。
  • 专科医生对合并症筛查不完整且未计算心血管风险。
  • 弹性成像联合血清生物标志物是最常用的一线纤维化分期方法。
  • 肝活检若进行,常在诊断后至少延迟1年,但即使无创方法提示进展期纤维化仍推荐肝活检。
  • 进行频繁的每半年监测,包括3期纤维化的HCC监测。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Differences between countries in NAFLD patient care pathways and management need to be understood prior to defining supranational guidelines. APPROACH AND RESULTS: We conducted an anonymous survey in France, Germany, Hong Kong, Italy, Romania, Spain, the United Kingdom, and the United States among physicians providing specialist care for patients with NAFLD. Modalities of patient referral, patterns of practice (diagnosis, staging, monitoring, and indications for liver biopsy), therapeutic management, and expectations for future NASH pharmacotherapies were assessed, with 664 physicians completing the survey. Referral to surveyed physicians (SPs) mostly came from primary care. Prior to referral, NAFLD was rarely diagnosed, and noninvasive tests were not performed. Screening for comorbidities by SPs was incomplete and cardiovascular risk not calculated. Elastometry in combination with a serum biomarker was the most common first-line method for fibrosis staging. Liver biopsy, when performed, was often delayed by at least 1 year after diagnosis. It was, however, recommended even if noninvasive methods indicated advanced fibrosis. Frequent, biannual monitoring was conducted, including HCC surveillance in Stage 3 fibrosis. SPs rarely implemented and followed dietary and lifestyle changes themselves, and local availability of such programs was highly heterogenous. SPs favored pharmacotherapy based on mechanism of action adapted to the stage of the disease, including for early stages such as steatohepatitis with mild fibrosis. CONCLUSIONS: This international survey revealed major deficiencies and delays in referral pathways, suboptimal screening for comorbidities or managing of lifestyle modifications by SPs, and limited local availability for nonpharmacological interventions. Monitoring practices are not aligned with current guidelines.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Ratziu V, Anstee QM, Wong VW, et al. An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT project. Hepatology. 2022. PMID: 35363906. doi:10.1002/hep.32500

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。